Related Experiment Videos
Bioactive constituents from Iryanthera megistophylla
Dong Sheng Ming1, Andrés López, Brian J Hillhouse
1Department of Botany, University of British Columbia, #3529-6270 University Boulevard, Vancouver, Canada V6T 1Z4.
Journal of Natural Products
|October 26, 2002
Summary
Researchers isolated two novel compounds, megislignan and megislactone, from Iryanthera megistophylla bark. These, along with seven known compounds, were tested for various biological activities, including antimicrobial and antiviral effects.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacognosy
Background:
- Iryanthera megistophylla is a plant species with potential medicinal properties.
- Natural products are a rich source of novel therapeutic agents.
Purpose of the Study:
- To isolate and characterize new chemical compounds from Iryanthera megistophylla stem bark.
- To evaluate the isolated compounds for biological activities such as antibacterial, antifungal, antiviral, and antiacetylcholinesterase properties.
Main Methods:
- Activity-guided fractionation of the 95% ethanol extract of Iryanthera megistophylla stem bark.
- Structure elucidation of new compounds using spectral data interpretation (e.g., NMR, MS).
- In vitro screening for antibacterial, antifungal, antiviral, and antiacetylcholinesterase activities.
Main Results:
- Two new compounds, megislignan and megislactone, were isolated and structurally identified.
- Seven known compounds (grandinolide, iryantherin K, iryantherin L, cinchonain I b, cinchonain I a, procyanidin B-2, and cinchonain IIa) were also identified.
- The isolated compounds were evaluated for their biological activities.
Conclusions:
- The study successfully identified novel chemical entities from Iryanthera megistophylla.
- Further investigation into the biological activities of these isolates may lead to the development of new therapeutic agents.